Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Systemic chemotherapy for bladder cancer
Der Urologe, 07/02/09
Retz M et al. - This review summarizes the results of first-line and second-line systemic chemotherapy for advanced urothelial carcinoma as well as data from adjuvant and neoadjuvant trials for locally advanced bladder cancer. Whereas conventional systemic chemotherapy prevailed for over two decades, targeted therapeutics have been introduced to treat urothelial cancer during recent years.
Related Articles
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
Cancer, 11/09/09
Relevance Score: 92%
Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients
Evidence-based Complementary and Alternative Medicine, 11/20/09
Relevance Score: 91%
Selective internal radiation therapy for liver metastases from colorectal cancer
Cochrane Reviews, 10/09/09
Relevance Score: 91%
Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
The Lancet Oncology - Online First, 10/30/09
Relevance Score: 90%
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Cancer, 10/20/09
Relevance Score: 90%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Menouria due to congenital vesicovaginal fistula associated with complex genitourinary malformation
Indian Journal of Urology, 12/16/09
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
World Journal of Urology, 12/16/09
Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
The Journal of Urology, 12/16/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
World Journal of Urology, 12/16/09
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaive castration-resistant prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/15/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study
PLoS Medicine, 12/16/09
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Prostate Cancer
Topics in Magnetic Resonance Imaging, 12/16/09
Article Search
Sponsor


See Latest Articles


